| Literature DB >> 21845066 |
Anna Del Fabro1, Lorenza Driul, Omar Anis, Ambrogio P Londero, Serena Bertozzi, Livio Bortotto, Diego Marchesoni.
Abstract
BACKGROUND: The purpose of this study was to evaluate the gender ratio and incidence of chromosomal anomalies in the products of conception (POC) from recurrent miscarriages.Entities:
Keywords: fetal gender; karyotype anomalies; recurrent miscarriages
Year: 2011 PMID: 21845066 PMCID: PMC3150206 DOI: 10.2147/IJWH.S20557
Source DB: PubMed Journal: Int J Womens Health ISSN: 1179-1411
Figure 1Male to female ratio in recurrent miscarriages (n = 313) by gestational age.
Reasons for miscarriage in normal karyotypes and abnormal karyotypes identified in products of conception in 313 recurrent abortions
| Idiopathic miscarriage | 49% (152/313) | 57% (113/199) | 34% (39/114) | <0.05 |
| 4–10 weeks | 44% (74/168) | 55% (62/113) | 22% (12/55) | <0.05 |
| 11–15 weeks | 42% (38/90) | 49% (25/51) | 33% (13/39) | 0.135 |
| 16–22 weeks | 72% (34/47) | 71% (20/28) | 74% (14/19) | 0.865 |
| Other maternal pathologies | 2% (6/313) | 2% (4/199) | 2% (2/114) | 0.874 |
| 4–10 weeks | 2% (3/168) | 3% (3/113) | 0% (0/55) | 0.223 |
| 11–15 weeks | 1% (1/90) | 0% (0/51) | 3% (1/39) | 0.250 |
| 16–22 weeks | 4% (2/47) | 4% (1/28) | 5% (1/19) | 0.778 |
| Infection/cervical incontinence/PROM | 2% (5/313) | 1% (2/199) | 3% (3/114) | 0.269 |
| 4–10 weeks | NA | NA | NA | |
| 11–15 weeks | 1% (1/90) | 0% (0/51) | 3% (1/39) | 0.250 |
| 16–22 weeks | 9% (4/47) | 7% (2/28) | 11% (2/19) | 0.683 |
| Trisomies | 27% (84/313) | 21% (41/199) | 38% (43/114) | <0.05 |
| 4–10 weeks | 36% (60/168) | 26% (29/113) | 56% (31/55) | <0.05 |
| 11–15 weeks | 24% (22/90) | 22% (11/51) | 28% (11/39) | 0.468 |
| 16–22 weeks | NA | NA | NA | |
| Monosomy X | 3% (8/313) | 4% (7/199) | 1% (1/114) | 0.154 |
| 4–10 weeks | 2% (3/168) | 3% (3/113) | 0% (0/55) | 0.223 |
| 11–15 weeks | 4% (4/90) | 6% (3/51) | 3% (1/39) | 0.449 |
| 16–22 weeks | 2% (1/47) | 4% (1/28) | 0% (0/19) | 0.405 |
| Triploidy | 7% (21/313) | 5% (9/199) | 11% (12/114) | <0.05 |
| 4–10 weeks | 7% (12/168) | 5% (6/113) | 11% (6/55) | 0.186 |
| 11–15 weeks | 9% (8/90) | 6% (3/51) | 13% (5/39) | 0.252 |
| 16–22 weeks | 2% (1/47) | 0% (0/28) | 5% (1/19) | 0.220 |
| Tetraploidy | 1% (4/313) | 2% (3/199) | 1% (1/114) | 0.633 |
| 4–10 weeks | 1% (2/168) | 2% (2/113) | 0% (0/55) | 0.321 |
| 11–15 weeks | 2% (2/90) | 2% (1/51) | 3% (1/39) | 0.847 |
| 16–22 weeks | NA | NA | NA | |
| Separate rearrangements | 5% (17/313) | 5% (10/199) | 6% (7/114) | 0.675 |
| 4–10 weeks | 7% (12/168) | 6% (7/113) | 9% (5/55) | 0.494 |
| 11–15 weeks | 2% (2/90) | 2% (1/51) | 3% (1/39) | 0.847 |
| 16–22 weeks | 6% (3/47) | 7.14% (2/28) | 5% (1/19) | 0.796 |
| Fetal malformation | 5% (16/313) | 5% (10/199) | 5% (6/114) | 0.927 |
| 4–10 weeks | 1% (2/168) | 1% (1/113) | 2% (1/55) | 0.601 |
| 11–15 weeks | 13% (12/90) | 14% (7/51) | 13% (5/39) | 0.900 |
| 16–22 weeks | 4% (2/47) | 7% (2/28) | 0% (0/19) | 0.234 |
Notes:
Separate rearrangements: 46, XX, −1, +der(1),t(1;18); 46, XX, −12, +der(12),t(11;12); 46, XX, der(4),t(4;8)mat; 46, XY, −5, +der(5),t(5:7); 46, XX, var(15p+),var(15p+) PCD.
Abbreviations: PROM, premature rupture of membranes; NA, not available.
Figure 2Trisomic distribution in male and female products of conception.
Gender distribution of live births at our clinic between 2001 and 2008
| 2001 | 47% (820/1730) | 53% (910/1730) | 0.423 |
| 2002 | 50% (894/1804) | 50% (910/1804) | 0.254 |
| 2003 | 46% (848/1833) | 54% (985/1833) | 0.061 |
| 2004 | 49% (868/1773) | 51% (905/1773) | 0.556 |
| 2005 | 49% (901/1840) | 51% (939/1840) | 0.541 |
| 2006 | 49% (875/1793) | 51% (918/1793) | 0.651 |
| 2007 | 49% (880/1796) | 51% (916/1796) | 0.528 |
| 2008 | 47% (854/1799) | 53% (945/1799) | 0.451 |